Enterprise
Healthcare AI ROI Leaders Run Larger Portfolios, Retire Tools Faster
Survey of nearly 400 hospitals finds operational discipline—not just technology spending—separates high performers from the rest.
Key takeaways
- High-ROI hospitals operate mature, scaled AI portfolios at twice the rate of lower performers (42% vs. 20%) and deploy across more domains (8.6 vs. 7.5).
- ROI leaders run a median of eight AI tools and retire two annually, compared to five tools and one retirement among lower performers.
- Nearly two-thirds of healthcare AI deployments deliver 2x ROI or better, with median returns of 2.5x across all respondents.
- Less-adopted domains like pharmacy, supply chain, and utilization management show stronger 3.0x median returns than widely deployed clinical care applications.
- Only 17% of high-ROI organizations reported AI-related layoffs; most redesigned roles, redeployed staff, or reduced overtime instead.
The hospitals and health systems extracting the highest returns from artificial intelligence investments share a common trait: they treat AI as a portfolio to be actively managed rather than a set-it-and-forget-it technology deployment.
According to a survey of 416 senior leaders at 385 acute-care hospitals and health systems, organizations reporting the strongest AI returns operate mature, scaled portfolios at more than twice the rate of their lower-performing peers—42% versus 20%. These high performers also deploy AI across a median of 8.6 clinical and operational domains, compared to 7.5 domains among organizations seeing weaker returns.
The survey was conducted by Vizient, a healthcare group purchasing organization and advisory firm, which released the findings on November 12.
Portfolio discipline drives performance
The distinction between AI ROI leaders and laggards centers on operational rigor. High-return organizations run a median of eight AI tools and retire two annually, compared to five tools and one retirement among lower performers. This active culling suggests successful hospitals continuously evaluate what's working and cut what isn't.
Workforce strategy also differs markedly. Only 17% of ROI leaders reported AI-related layoffs. Instead, 59% redesigned roles, 56% redeployed staff to higher-value work, 53% reduced overtime, and 21% reduced headcount through attrition.
Strong returns across most deployments
Nearly two-thirds of AI deployments delivered returns of at least 2x investment, with a median ROI of 2.5x and a mean of 3.2x across all respondents. Some of the strongest returns came from domains with lower adoption rates: pharmacy (36% adoption), supply chain (48%), and utilization management (48%) each reported a median 3.0x ROI.
By contrast, the most widely adopted use cases—clinical care (92% adoption), care management (76%), and patient access (71%)—returned closer to 2x. The data suggests early movers in less-saturated domains may capture outsized value.
Why it matters
As healthcare organizations face mounting pressure to demonstrate value from AI investments, this survey provides a roadmap beyond vendor promises. The findings challenge the notion that simply deploying more AI tools drives better outcomes. Instead, success appears to hinge on disciplined portfolio management, strategic workforce redesign, and targeted deployment in high-impact domains. For health system executives weighing AI budgets, the message is clear: operational maturity matters more than technology spending alone.
Terry Hemken, managing director and practice leader for advanced technology at Kaufman Hall, a Vizient company, said the findings suggest hospitals need to move beyond broad AI applications. Organizations should "focus on specific use cases where the technology can solve meaningful problems and deliver measurable value," Hemken noted. "A disciplined approach will help health systems prioritize investments and scale what works."
The full survey report is available at no cost from Vizient. Details were first reported by Health Exec.